Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek LeRoith

Showing results (131-140 of 304) with videos related to

Pageof 31
Sort By:
Plos One|December 4, 2009
High-efficient FLPo deleter mice in C57BL/6J backgroundYingjie Wu, Chunxin Wang, Hui Sun, et al.
Diabetes|December 5, 2009
Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progressionYvonne Fierz, Ruslan Novosyadlyy, Archana Vijayakumar, et al.
Endocrine-Related Cancer|August 31, 2010
Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetesYvonne Fierz, Ruslan Novosyadlyy, Archana Vijayakumar, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 16, 2010
The pathway from diabetes and obesity to cancer, on the route to targeted therapyEmily J Gallagher, Yvonne Fierz, Rosalyn D Ferguson, et al.
Endocrine Development|May 10, 2005
Clinical relevance of systemic and local IGF-IShoshana Yakar, Patricia Pennisi, Yiping Wu, et al.
Handbook of Experimental Pharmacology|April 24, 2015
Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential MechanismsSarit Ben-Shmuel, Ran Rostoker, Eyal J Scheinman, et al.
Journal of Diabetes and Its Complications|May 21, 2016
Polyol accumulation in muscle and liver in a mouse model of type 2 diabetesEmily J Gallagher, Derek LeRoith, Marilyn Stasinopoulos, et al.
The Journal of Clinical Investigation|September 18, 2002
PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epitheliumJoëlle Dupont, Jean Pierre Renou, Moshe Shani, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 20, 2022
Metformin and Cancer: Is This the End?Emily J Gallagher, Nathan G Kase, Nina A Bickell, et al.
Endocrine-Related Cancer|October 18, 2022
Unregulated LDL cholesterol uptake is detrimental to breast cancer cellsTiffany Scully, Abora Ettela, Nathan Kase, et al.
Pageof 31

Showing results (131-140 of 304) with videos related to

Sort By:
Pageof 31
Plos One|December 4, 2009
High-efficient FLPo deleter mice in C57BL/6J backgroundYingjie Wu, Chunxin Wang, Hui Sun, et al.
Diabetes|December 5, 2009
Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progressionYvonne Fierz, Ruslan Novosyadlyy, Archana Vijayakumar, et al.
Endocrine-Related Cancer|August 31, 2010
Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetesYvonne Fierz, Ruslan Novosyadlyy, Archana Vijayakumar, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 16, 2010
The pathway from diabetes and obesity to cancer, on the route to targeted therapyEmily J Gallagher, Yvonne Fierz, Rosalyn D Ferguson, et al.
Endocrine Development|May 10, 2005
Clinical relevance of systemic and local IGF-IShoshana Yakar, Patricia Pennisi, Yiping Wu, et al.
Handbook of Experimental Pharmacology|April 24, 2015
Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential MechanismsSarit Ben-Shmuel, Ran Rostoker, Eyal J Scheinman, et al.
Journal of Diabetes and Its Complications|May 21, 2016
Polyol accumulation in muscle and liver in a mouse model of type 2 diabetesEmily J Gallagher, Derek LeRoith, Marilyn Stasinopoulos, et al.
The Journal of Clinical Investigation|September 18, 2002
PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epitheliumJoëlle Dupont, Jean Pierre Renou, Moshe Shani, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 20, 2022
Metformin and Cancer: Is This the End?Emily J Gallagher, Nathan G Kase, Nina A Bickell, et al.
Endocrine-Related Cancer|October 18, 2022
Unregulated LDL cholesterol uptake is detrimental to breast cancer cellsTiffany Scully, Abora Ettela, Nathan Kase, et al.
Pageof 31